Effects of sitagliptin addition versus sulfonylurea intensification on beta cell function in patients with type 2 diabetes inadequately controlled on sulfonylurea: a randomized, multicenter, open-label trial.

Trial Profile

Effects of sitagliptin addition versus sulfonylurea intensification on beta cell function in patients with type 2 diabetes inadequately controlled on sulfonylurea: a randomized, multicenter, open-label trial.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Sitagliptin (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2012 Last checked against University Hospital Medical Information Network - Japan record.
    • 19 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top